# FDA recall D-765-2014

> **Aidapak Services, LLC** · Class II · drug recall initiated 2013-07-02.

## Product

ATOMOXETINE HCL, Capsule, 40 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00002322930.

## Reason for recall

Labeling: Label Mixup: ATOMOXETINE HCL, Capsule, 40 mg may be potentially mis-labeled as OLANZAPINE, Tablet, 7.5 mg, NDC 60505311203, Pedigree: AD21790_76, EXP: 5/1/2014;  ARIPiprazole, Tablet, 2 mg, NDC 59148000613, Pedigree: AD46265_19, EXP: 5/15/2014;  OLANZapine, Tablet, 7.5 mg, NDC 55111016530, Pedigree: AD60272_79, EXP: 5/22/2014;  OLANZapine, Tablet, 7.5 mg, NDC 55111016530, Pedigree:  AD73

## Distribution

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

## Key facts

- **Recall number:** D-765-2014
- **Recalling firm:** Aidapak Services, LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-07-02
- **Report date:** 2014-01-29
- **Termination date:** 2014-02-07

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Vancouver, WA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-765-2014

## Citation

> AI Analytics. FDA recall D-765-2014. Retrieved 2026-05-24 from https://api.ai-analytics.org/recall/D-765-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*